These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1199 related articles for article (PubMed ID: 26151310)
1. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway. Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310 [TBL] [Abstract][Full Text] [Related]
2. Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study. Arutyunyan I; Fatkhudinov T; Kananykhina E; Usman N; Elchaninov A; Makarov A; Bolshakova G; Goldshtein D; Sukhikh G Stem Cell Res Ther; 2016 Mar; 7():46. PubMed ID: 27001300 [TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of porcine mesenchymal stem cells derived from bone marrow and umbilical cord: implication of the proteins involved in the higher migration capability of bone marrow mesenchymal stem cells. Huang L; Niu C; Willard B; Zhao W; Liu L; He W; Wu T; Yang S; Feng S; Mu Y; Zheng L; Li K Stem Cell Res Ther; 2015 Apr; 6(1):77. PubMed ID: 25889491 [TBL] [Abstract][Full Text] [Related]
4. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
5. Human Umbilical Cord Mesenchymal Stem Cells Promote Breast Cancer Metastasis by Interleukin-8- and Interleukin-6-Dependent Induction of CD44(+)/CD24(-) Cells. Ma F; Chen D; Chen F; Chi Y; Han Z; Feng X; Li X; Han Z Cell Transplant; 2015; 24(12):2585-99. PubMed ID: 25695620 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell‑derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway. Zhou X; Li T; Chen Y; Zhang N; Wang P; Liang Y; Long M; Liu H; Mao J; Liu Q; Sun X; Chen H Int J Oncol; 2019 May; 54(5):1843-1852. PubMed ID: 30864702 [TBL] [Abstract][Full Text] [Related]
7. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis. Shen C; Lie P; Miao T; Yu M; Lu Q; Feng T; Li J; Zu T; Liu X; Li H Mol Med Rep; 2015 Jul; 12(1):20-30. PubMed ID: 25739039 [TBL] [Abstract][Full Text] [Related]
8. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057 [TBL] [Abstract][Full Text] [Related]
9. Differentiated pre-adipocytes promote proliferation, migration and epithelial-mesenchymal transition in breast cancer cells of different p53 status. Avşar Abdik E Mol Biol Rep; 2021 Jun; 48(6):5187-5198. PubMed ID: 34213707 [TBL] [Abstract][Full Text] [Related]
10. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089 [TBL] [Abstract][Full Text] [Related]
11. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications. Van Pham P; Truong NC; Le PT; Tran TD; Vu NB; Bui KH; Phan NK Cell Tissue Bank; 2016 Jun; 17(2):289-302. PubMed ID: 26679929 [TBL] [Abstract][Full Text] [Related]
12. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT. Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718 [TBL] [Abstract][Full Text] [Related]
13. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. De Luca A; Lamura L; Gallo M; Maffia V; Normanno N J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871 [TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach. Zhang H; Zhang B; Tao Y; Cheng M; Hu J; Xu M; Chen H Cell Biochem Funct; 2012 Dec; 30(8):643-9. PubMed ID: 22777760 [TBL] [Abstract][Full Text] [Related]
16. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282 [TBL] [Abstract][Full Text] [Related]
17. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition. Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783 [TBL] [Abstract][Full Text] [Related]
18. Explants-isolated human placenta and umbilical cord cells share characteristics of both epithelial and mesenchymal stem cells. Anastasiu DM; Cean A; Bojin MF; Gluhovschi A; Panaitescu C; Păunescu V; Tănăsie G Rom J Morphol Embryol; 2016; 57(2):383-90. PubMed ID: 27516009 [TBL] [Abstract][Full Text] [Related]
19. Neurosphere formation enhances the neurogenic differentiation potential and migratory ability of umbilical cord-mesenchymal stromal cells. Mukai T; Nagamura-Inoue T; Shimazu T; Mori Y; Takahashi A; Tsunoda H; Yamaguchi S; Tojo A Cytotherapy; 2016 Feb; 18(2):229-41. PubMed ID: 26794714 [TBL] [Abstract][Full Text] [Related]
20. N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells. Choi S; Yu J; Kim W; Park KS Theranostics; 2021; 11(14):6786-6799. PubMed ID: 34093853 [No Abstract] [Full Text] [Related] [Next] [New Search]